DE69839557D1 - Klonierte genome von infektiösen hepatitis c viren und deren verwendungen - Google Patents
Klonierte genome von infektiösen hepatitis c viren und deren verwendungenInfo
- Publication number
- DE69839557D1 DE69839557D1 DE69839557T DE69839557T DE69839557D1 DE 69839557 D1 DE69839557 D1 DE 69839557D1 DE 69839557 T DE69839557 T DE 69839557T DE 69839557 T DE69839557 T DE 69839557T DE 69839557 D1 DE69839557 D1 DE 69839557D1
- Authority
- DE
- Germany
- Prior art keywords
- viruses
- infectious hepatitis
- cloned genome
- sequences
- hcv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000711557 Hepacivirus Species 0.000 title abstract 2
- 208000037319 Hepatitis infectious Diseases 0.000 title abstract 2
- 208000005252 hepatitis A Diseases 0.000 title abstract 2
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000007423 screening assay Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5306297P | 1997-07-18 | 1997-07-18 | |
US09/014,416 US6153421A (en) | 1997-07-18 | 1998-01-27 | Cloned genomes of infectious hepatitis C viruses and uses thereof |
PCT/US1998/014688 WO1999004008A2 (en) | 1997-07-18 | 1998-07-16 | Cloned genomes of infectious hepatitis c viruses and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69839557D1 true DE69839557D1 (de) | 2008-07-10 |
Family
ID=26686065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69839557T Expired - Lifetime DE69839557D1 (de) | 1997-07-18 | 1998-07-16 | Klonierte genome von infektiösen hepatitis c viren und deren verwendungen |
Country Status (7)
Country | Link |
---|---|
US (3) | US6153421A (de) |
EP (1) | EP0998567B1 (de) |
AT (1) | ATE397070T1 (de) |
AU (1) | AU746965B2 (de) |
CA (1) | CA2295552C (de) |
DE (1) | DE69839557D1 (de) |
WO (1) | WO1999004008A2 (de) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7235394B1 (en) * | 1995-08-29 | 2007-06-26 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
US6127116A (en) * | 1995-08-29 | 2000-10-03 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
US7338759B1 (en) | 1997-03-04 | 2008-03-04 | Washington University | HCV variants |
US6153421A (en) * | 1997-07-18 | 2000-11-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Cloned genomes of infectious hepatitis C viruses and uses thereof |
EP1036847B1 (de) * | 1999-02-03 | 2004-10-27 | Ortho-Clinical Diagnostics, Inc. | Oligonukleotid Primer zur effizienten reversen Transkription von Hepatitis C Virus (HCV) RNS und Verfahren zu deren Verwendung |
DE19915178A1 (de) * | 1999-04-03 | 2000-10-05 | Univ Mainz Johannes Gutenberg | Hepatitis C Virus Zellkultursystem |
AU7602800A (en) * | 1999-09-23 | 2001-04-24 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof |
US6995299B2 (en) * | 1999-11-02 | 2006-02-07 | University Of Connecticut | Propagation of human hepatocytes in non-human animals |
CA2414421A1 (en) * | 2000-07-31 | 2002-02-07 | Gene Logic, Inc. | Molecular toxicology modeling |
US7590493B2 (en) * | 2000-07-31 | 2009-09-15 | Ocimum Biosolutions, Inc. | Methods for determining hepatotoxins |
AU2001292151B2 (en) * | 2000-08-17 | 2006-05-04 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
US6680059B2 (en) * | 2000-08-29 | 2004-01-20 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
US7022830B2 (en) * | 2000-08-17 | 2006-04-04 | Tripep Ab | Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
RU2286172C2 (ru) * | 2000-08-17 | 2006-10-27 | Трипеп Аб | Вакцины, содержащие рибавирин, и способы их использования |
GB0021859D0 (en) * | 2000-09-06 | 2000-10-18 | Imp College Innovations Ltd | Methods |
EP1421222A4 (de) * | 2001-03-09 | 2004-07-07 | Univ California | Zellkultursystem zur synthese von infektiösem hepatitis-c-virus |
FR2824072B1 (fr) * | 2001-04-27 | 2004-03-12 | Centre Nat Rech Scient | Procede de replication et de production du virus de l'hepatite c |
WO2002090572A2 (en) * | 2001-05-09 | 2002-11-14 | Third Wave Technologies, Inc. | Nucleic acid detection in pooled samples |
CA2447357A1 (en) * | 2001-05-22 | 2002-11-28 | Gene Logic, Inc. | Molecular toxicology modeling |
US20070015146A1 (en) * | 2001-05-22 | 2007-01-18 | Gene Logic, Inc. | Molecular nephrotoxicology modeling |
AU2002365904A1 (en) * | 2001-07-10 | 2003-09-04 | Gene Logic, Inc. | Cardiotoxin molecular toxicology modeling |
US20070054269A1 (en) * | 2001-07-10 | 2007-03-08 | Mendrick Donna L | Molecular cardiotoxicology modeling |
US7447594B2 (en) * | 2001-07-10 | 2008-11-04 | Ocimum Biosolutions, Inc. | Molecular cardiotoxicology modeling |
CU23244A1 (es) * | 2001-07-16 | 2007-10-17 | Ct Ingenieria Genetica Biotech | Formulacion vacunal potenciada por la combinacion de un adn con un antigeno |
US7745418B2 (en) * | 2001-10-12 | 2010-06-29 | Alnylam Pharmaceuticals, Inc. | Compositions and methods for inhibiting viral replication |
US6689559B2 (en) | 2001-11-29 | 2004-02-10 | The Research Foundation Of The State University Of New York | Efficient hepatitis C virus replicon and its use in identifying antiviral compounds |
JP2005535285A (ja) * | 2002-01-31 | 2005-11-24 | ジーン ロジック インコーポレイテッド | 分子肝毒性モデリング |
ES2321498T3 (es) * | 2002-03-11 | 2009-06-08 | Lab 21 Limited | Metodos y composiciones para identificar y caracterizar la hepatitis c. |
FR2848572B1 (fr) * | 2002-12-12 | 2005-12-09 | Univ Joseph Fourier | Molecules inhibitrices de la synthese proteique du virus de l'hepatite c et procede de criblage desdites molecules inhibitrices |
JP2007501617A (ja) * | 2003-08-07 | 2007-02-01 | ジーン ロジック インコーポレイテッド | 初代ラット肝細胞毒性モデリング |
US20080281526A1 (en) * | 2004-03-22 | 2008-11-13 | Diggans James C | Methods For Molecular Toxicology Modeling |
WO2005100989A2 (en) * | 2004-04-07 | 2005-10-27 | Gene Logic, Inc. | Hepatotoxicity molecular models |
ATE505541T1 (de) * | 2004-09-24 | 2011-04-15 | Alnylam Pharmaceuticals Inc | Targeting von zwischenprodukten zur gegenstrangreplikation von einzelstrangigen viren durch rnai |
ES2349153T3 (es) * | 2004-09-29 | 2010-12-28 | The Administrators Of The Tulane Educational Fund | Inhibidores del virus de la hepatitis c. |
WO2007031867A2 (en) * | 2005-05-25 | 2007-03-22 | Tripep Ab | A hepatitis c virus non-stru tural ns3/4a fusion gene |
WO2008125117A1 (en) | 2007-04-13 | 2008-10-23 | Hvidovre Hospital | Cell culture system of a hepatitis c genotype 3a and 2a chimera |
US8454974B2 (en) | 2007-04-13 | 2013-06-04 | Hvidovre Hospital | Adaptive mutations allow establishment of JFH1-based cell culture systems for hepatitis C virus genotype 4A |
WO2008141651A1 (en) | 2007-05-18 | 2008-11-27 | Hvidovre Hospital | Efficient cell culture system for hepatitis c virus genotype 5a |
US8071561B2 (en) | 2007-08-16 | 2011-12-06 | Chrontech Pharma Ab | Immunogen platform |
US20090214593A1 (en) * | 2007-08-16 | 2009-08-27 | Tripep Ab | Immunogen platform |
US8563706B2 (en) | 2007-12-20 | 2013-10-22 | Hvidovre Hospital | Efficient cell culture system for hepatitis C virus genotype 1A and 1B |
US8569472B2 (en) | 2007-12-20 | 2013-10-29 | Hvidovre Hospital | Efficient cell culture system for hepatitis C virus genotype 6A |
US8323891B2 (en) * | 2008-08-01 | 2012-12-04 | Claflin University | miRNA triplex formations for the downregulation of viral replication |
US8506969B2 (en) | 2008-08-15 | 2013-08-13 | Hvidovre Hospital | Efficient cell culture system for hepatitis C virus genotype 7a |
WO2010017818A1 (en) | 2008-08-15 | 2010-02-18 | Hvidovre Hospital | Efficient cell culture system for hepatitis c virus genotype 2b |
US8772022B2 (en) | 2008-10-03 | 2014-07-08 | Hvidovre Hospital | Hepatitis C virus expressing reporter tagged NS5A protein |
JP2012513757A (ja) * | 2008-12-31 | 2012-06-21 | アボット・ラボラトリーズ | C型肝炎ウイルスの検出用プライマー及びプローブ |
JP2012515534A (ja) * | 2009-01-21 | 2012-07-12 | バーテックス ファーマシューティカルズ インコーポレイテッド | C型肝炎ウイルス核酸を増幅する方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5679342A (en) * | 1987-11-18 | 1997-10-21 | Chiron Corporation | Hepatitis C virus infected cell systems |
CA2065690A1 (en) * | 1991-04-10 | 1992-10-11 | Hiroaki Okamoto | Non-a, non-b hepatitis related antigens, detection systems, polynucleotides and polypeptides |
US5874565A (en) * | 1995-08-29 | 1999-02-23 | Washington University | Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus |
US6127116A (en) * | 1995-08-29 | 2000-10-03 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
US6153421A (en) * | 1997-07-18 | 2000-11-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Cloned genomes of infectious hepatitis C viruses and uses thereof |
US7084266B1 (en) * | 1999-06-04 | 2006-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Cloned genome of infectious hepatitus C virus of genotype 2A and uses thereof |
-
1998
- 1998-01-27 US US09/014,416 patent/US6153421A/en not_active Expired - Lifetime
- 1998-07-16 AT AT98935702T patent/ATE397070T1/de not_active IP Right Cessation
- 1998-07-16 WO PCT/US1998/014688 patent/WO1999004008A2/en active IP Right Grant
- 1998-07-16 DE DE69839557T patent/DE69839557D1/de not_active Expired - Lifetime
- 1998-07-16 EP EP98935702A patent/EP0998567B1/de not_active Expired - Lifetime
- 1998-07-16 CA CA2295552A patent/CA2295552C/en not_active Expired - Lifetime
- 1998-07-16 AU AU84889/98A patent/AU746965B2/en not_active Expired
-
2000
- 2000-09-14 US US09/662,454 patent/US7201911B1/en not_active Expired - Fee Related
-
2007
- 2007-04-09 US US11/784,809 patent/US7846454B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0998567A2 (de) | 2000-05-10 |
CA2295552A1 (en) | 1999-01-28 |
WO1999004008A2 (en) | 1999-01-28 |
WO1999004008A3 (en) | 1999-04-01 |
AU8488998A (en) | 1999-02-10 |
US6153421A (en) | 2000-11-28 |
AU746965B2 (en) | 2002-05-09 |
US7201911B1 (en) | 2007-04-10 |
US7846454B2 (en) | 2010-12-07 |
ATE397070T1 (de) | 2008-06-15 |
US20080014212A1 (en) | 2008-01-17 |
EP0998567B1 (de) | 2008-05-28 |
CA2295552C (en) | 2013-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69839557D1 (de) | Klonierte genome von infektiösen hepatitis c viren und deren verwendungen | |
ATE366314T1 (de) | Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays | |
PT977587E (pt) | Vacinas quimericas de flavivirus | |
DK0637342T3 (da) | Fremgangsmåde til typebestemmelse af HCV-isolater | |
DE59109221D1 (de) | HCV-spezifische Peptide, Mittel dazu und ihre Verwendung | |
DE69532369D1 (de) | Rekombinantes infektiöses nicht-in-Segmente-geteiltes, negativ-Strange-RNS-Virus | |
DK0783321T3 (da) | VR-2332 viral nucleotidsekvens og fremgangsmåder til anvendelse | |
ATE241014T2 (de) | Hiv-2 varianten | |
PT698216E (pt) | Metodos de tipificacao do virus da hepatite c e reagentes para utilizar nestes | |
DE69839403D1 (de) | Adenovirale vektoren und eine methode zur reduktion von homologer rekombination | |
DE60034884D1 (de) | Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen | |
WO2001021807A8 (en) | Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof | |
DE3853693D1 (de) | DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung. | |
ATE346087T1 (de) | Hepatitis e-virus aus dem schwein und dessen verwendungen | |
WO2000075352A3 (en) | Hcv/bvdv chimeric genomes and uses thereof | |
DE69837437D1 (de) | Gen, polynukleotid, polypeptid und virion des non-b, non-c, non-g-hepatitis virus, eine methode zur abtrennung dieses virions und methoden für die virusdetektion. | |
WO1997040166A3 (en) | Simian-human hav having a chimeric 2c protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |